Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Gene Targeting to Hepatomas (AFP).

S Tsuruta¹, A Ido, S Nagataki

¹The First Department of Internal Medicine, Nagasaki University School of Medicine, Nakgasaki, Japan.

Methods in Molecular Medicine

|March 11, 2011

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transcriptional activities of two newly identified Haemaphysalis longicornis tick-derived promoter regions in the Ixodes scapularis tick cell line (ISE6).

Insect molecular biology·2018

Same author

Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.

Alimentary pharmacology & therapeutics·2017

Same author

Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases.

Alimentary pharmacology & therapeutics·2017

Same author

Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies.

Clinical pharmacology and therapeutics·2017

Same author

Evaluation of a Proton Pump Inhibitor for Sleep Bruxism: A Randomized Clinical Trial.

Journal of dental research·2016

Same author

Enhanced expression of hepatitis B surface antigen by sodium butyrate in PLC/PRF/5 human hepatoma cells.

International journal of oncology·2011

Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015

Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014

Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014

Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014

Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014

Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014

See all related articles

Gene therapy using the herpes simplex virus thymidine kinase (HSV-tk) gene offers a potential treatment for hepatocellular carcinoma (HCC). This approach leverages the gene

Area of Science:

Oncology
Molecular Biology
Gene Therapy

Background:

Hepatocellular carcinoma (HCC) presents a significant global health challenge with a poor prognosis, particularly in Eastern Asia and Africa.
Gene therapy is emerging as a promising strategy for treating various human diseases, including cancers.
The herpes simplex virus thymidine kinase (HSV-tk) gene therapy approach has shown potential for cancer treatment.

Purpose of the Study:

To explore the potential of gene therapy, specifically using the herpes simplex virus thymidine kinase (HSV-tk) gene, for treating hepatocellular carcinoma (HCC).
To elucidate the mechanism of action for HSV-tk gene therapy in cancer treatment, including its role in DNA synthesis inhibition and the bystander effect.

Main Methods:

Transduction of the herpes simplex virus thymidine kinase (HSV-tk) gene into tumor cells.

More Related Videos

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Related Experiment Videos

Last Updated: Jun 3, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Utilizing the enzymatic activity of HSV-tk to phosphorylate nucleoside analogs.

Leveraging the bystander effect for enhanced therapeutic outcomes in neighboring malignant cells.

Main Results:

The HSV-tk gene product effectively phosphorylates nucleoside analogs.
Phosphorylated nucleoside analogs act as chain terminators, inhibiting DNA synthesis and leading to cell death.
The bystander effect contributes to the overall efficacy of suicide gene therapy by enabling the diffusion of active agents to adjacent tumor cells.

Conclusions:

Suicide gene therapy utilizing the HSV-tk gene is a viable strategy for targeting hepatocellular carcinoma (HCC).
The mechanism involves prodrug activation, DNA synthesis inhibition, and a crucial bystander effect.
Further research into gene delivery and optimization is warranted for successful clinical application in HCC treatment.